We are seeking an experienced Clinical Trial Manager to serve as the operational project lead for Alpine’s first-in-class novel immunotherapeutic…
Read More
We are seeking an in-house Senior Clinical Research Associate to assist with operational oversight of Alpine’s clinical development program for…
— Data Presented at 59th American Society of Hematology Annual Meeting & Exposition — SEATTLE, December 9, 2017 – Alpine…
— Data Presented at 2017 San Antonio Breast Cancer Symposium –– SEATTLE, December 6, 2017 – Alpine Immune Sciences, Inc….
New preclinical data to be presented at multiple upcoming scientific meetings Strong balance sheet with $87.2 million in cash, cash…
— Company’s vIgD Platform Well Positioned to Realize Next Generation Immuno-Oncology Therapeutics — SEATTLE, November 10, 2017 – Alpine Immune…
–Poster to be Presented at 2017 ACR/ARHP Annual Meeting– SEATTLE, November 6, 2017 – Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a…
SEATTLE, WA – October, 23, 2017— Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing treatments for…
SEATTLE, WA — (BUSINESS WIRE)– October 16, 2017– Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading immunotherapy company focused on developing…
Alpine Immune Sciences Announces Poster Presentation at 2017 ACR/ARHP Annual Meeting SEATTLE, WA–(BUSINESS WIRE)—September 20, 2017– Alpine Immune Sciences, Inc….